Name | N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]-4-(1-hydroxy-2-methylpropan-2-yl)benzenesulfonamide |
---|---|
Synonyms |
4-(2-Hydroxy-1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-benzenesulfonamide
Hydroxy Bosentan Ro 48-8634 Benzenesulfonamide,4-(2-hydroxy-1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl] Ro 48-5033 Bosentan Impurity 2 |
Description | Hydroxy bosentan (Ro 48-5033) is a primary metabolite of Bosentan (BOS) metabolized by the cytochrome P450 system in the liver. Ro 48-5033 assists BOS pharmacologically, retaining 10%-20% activities[1]. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
References |
Density | 1.372g/cm3 |
---|---|
Boiling Point | 783.9ºC at 760 mmHg |
Molecular Formula | C27H29N5O7S |
Molecular Weight | 567.61300 |
Flash Point | 427.9ºC |
Exact Mass | 567.17900 |
PSA | 174.26000 |
LogP | 4.33010 |
Vapour Pressure | 7.01E-26mmHg at 25°C |
Index of Refraction | 1.619 |